Sub4Sub network gives free YouTube subscribers
Multiple Myeloma Research: Risks benefits of stem cell transplant | Dana-Farber Cancer Institute
DanaFarber research into autologous stem cell transplant for patients with multiple myeloma: study led by Dr. Paul G. Richardson, MD, found patients had dramatically increased progressionfree survival, but were just as likely to be alive more than 6 years later if they chose to reserve their transplant until later. Press release: https://bit.ly/3cgaZ7l Video published: 7/14/22
Recommended
